Welcome to the Daily News Brief, CFR’s flagship morning newsletter summarizing the top global news and analysis of the ...

U.S. pharma companies should pay rather more of their corporate income tax in the U.S.—and start producing more of their best drugs in the U.S. as well.

The United States joined Israel’s bombing campaign of Iran’s nuclear program. A clear picture of the damage inside Iran—and ...

A shell-shocked President Tinubu traveled to Makurdi, the Benue State capital, where he directed security agencies to “hunt ...

Welcome to the Daily News Brief, CFR’s flagship morning newsletter summarizing the top global news and analysis of the ...

Despite the impressive advances in airpower since the 1950s—like the precision-guided munitions employed in Saturday’s attack ...

While the war between Israel and Iran is drawing attention away from Gaza, it’s worth seeing what Hamas is doing: killing civilians who seek food.

This Week,” a series that highlights noteworthy news related to women and U.S. foreign policy. This week’s post covers June ...

After a week of Israeli attacks on its top military leaders and nuclear infrastructure, Iran’s autocratic regime still ...

The Biden administration released new export controls on Monday, January 13, placing restrictions on advanced AI chips, cloud access, and model weights. The measures’ implementation will rely on ...

Sign up to receive CFR President Mike Froman’s analysis on the most important foreign policy story of the week, delivered to ...

Rebecca Lissner is a senior fellow for U.S. foreign policy at the Council on Foreign Relations (CFR). Dr. Lissner is a leading scholar of American grand strategy who has served in senior national ...